1-4 of 4
Shili Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors

Available to Purchase
Ann M. Chan, Tove Olafsen, Jessica Tsui, Felix B. Salazar, Brian Aguirre, Kirstin A. Zettlitz, Michael Condro, Anna M. Wu, Jonathan Braun, Lynn K. Gordon, Negin Ashki, Julian Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (6): 890–903.
https://doi.org/10.1158/1535-7163.MCT-23-0465
Published: 04 June 2024
View articletitled, 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
Open the PDF for 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract B37: Targeting the energy generation triangle to achieve synthetic lethality for treatment of hepatocellular carcinoma

Free
Shili Xu, Arthur Catapang, Daniel Braas, Linsey Stiles, Jason T. Lee, Thomas G. Graeber, Robert Damoiseaux, Orian Shirihai, Harvey R. Herschman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (10_Supplement): B37.
https://doi.org/10.1158/1538-8514.SYNTHLETH-B37
Published: 02 October 2017
View articletitled, Abstract B37: Targeting the energy generation triangle to achieve synthetic lethality for treatment of hepatocellular carcinoma
Journal Articles

Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer

Free
Shili Xu, Fedora Grande, Antonio Garofalo, Nouri Neamati
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 937–949.
https://doi.org/10.1158/1535-7163.MCT-12-1082
Published: 09 June 2013
View articletitled, Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer
Open the PDF for Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract C148: SC144: The first orally active small molecule gp130 inhibitor for the treatment of ovarian cancer.

Free
Shili Xu, Fedora Grande, Antonio Garofalo, Nouri Neamati
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C148.
https://doi.org/10.1158/1535-7163.TARG-11-C148
Published: 12 November 2011
View articletitled, Abstract C148: SC144: The first orally active small molecule gp130 inhibitor for the treatment of ovarian cancer.